News
-
Advancing patient-led science through collaboration
The Rare As One Cycle 2 Impact Report highlights how patient communities are accelerating research and reshaping the rare disease landscape.
-
MIT Technology Review: How healthy am I? My immunome knows the score.
-
A Deep Look at the Immune System
Sjoukje van der Stegen, a Biohub group lead, is working to understand immune cell development with hopes of expanding access to immunotherapies
-
Reasoning with cells
rBio is our new reasoning model trained on virtual cell simulations, helping scientists predict the effect of gene mutations through plain language questions.
-
Core Memory: Priscilla Chan and her quest to end disease
In today's changing health landscape, these leaders are advancing care, shaping policy, and driving innovations that transform lives.
-
Inside Precision Medicine: Mogwai masters — CZI’s GREmLN is transforming AI to think like biology
-
GEN: CZI’s AI model captures gene networks to address disease
-
New CZI AI Model Could Help Scientists Pinpoint Signs of Cancer Cells
CZI announced its latest AI model, GREmLN, aimed at helping researchers better understand how cells behave by focusing on the key networks that control cell behavior
-
Teaching AI To Think Like A Cell
GREmLN, a new kind of AI model, is trained in ‘molecular logic’ and could unlock new frontiers in cancer research.
-
Ground Truths: New Center for Pediatric CRISPR Cures
-
Why we’re going all in on biology and AI
From virtual cells to virtual staining, Priscilla Chan highlights how AI models are helping researchers understand biology like never before.
-
Stanley P. Reimann Honor Award bestowed upon renowned biologist Andrea Califano